Alibaba Health Information Technology Limited
ALBBY · OTC
9/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Revenue | $2,321 | $16,325 | $8,162 | $14,274 |
| % Growth | -85.8% | 100% | -42.8% | – |
| Cost of Goods Sold | $1,740 | $12,426 | $6,213 | $10,740 |
| Gross Profit | $580 | $3,898 | $1,949 | $3,534 |
| % Margin | 25% | 23.9% | 23.9% | 24.8% |
| R&D Expenses | $44 | $401 | $200 | $319 |
| G&A Expenses | $0 | $225 | $112 | $183 |
| SG&A Expenses | $381 | $2,804 | $1,402 | $2,429 |
| Sales & Mktg Exp. | $0 | $1,278 | $639 | $981 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $425 | $3,205 | $1,603 | $2,748 |
| Operating Income | $156 | $693 | $347 | $785 |
| % Margin | 6.7% | 4.2% | 4.2% | 5.5% |
| Other Income/Exp. Net | $43 | $46 | $23 | $36 |
| Pre-Tax Income | $199 | $739 | $369 | $821 |
| Tax Expense | $23 | $76 | $38 | $52 |
| Net Income | $176 | $663 | $332 | $769 |
| % Margin | 7.6% | 4.1% | 4.1% | 5.4% |
| EPS | 0.22 | 0.82 | 0.41 | 0.96 |
| % Growth | -73.2% | 100% | -57.3% | – |
| EPS Diluted | 0.22 | 0.82 | 0.41 | 0.96 |
| Weighted Avg Shares Out | 806 | 809 | 809 | 804 |
| Weighted Avg Shares Out Dil | 810 | 809 | 809 | 805 |
| Supplemental Information | – | – | – | – |
| Interest Income | $32 | $255 | $127 | $231 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $3 | $19 | $9 | $13 |
| EBITDA | $204 | $700 | $350 | $786 |
| % Margin | 8.8% | 4.3% | 4.3% | 5.5% |